Sumi Shrishrimal - 30 Nov 2023 Form 4 Insider Report for iRhythm Technologies, Inc. (IRTC)

Signature
/s/ Marc Rosenbaum, attorney-in-fact
Issuer symbol
IRTC
Transactions as of
30 Nov 2023
Net transactions value
-$856,696
Form type
4
Filing time
27 Feb 2025, 16:07:03 UTC
Previous filing
05 Jun 2023
Next filing
01 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRTC Common Stock Other $12,033 +166 +0.71% $72.49 23,464 30 Nov 2023 Direct F1
transaction IRTC Common Stock Other $13,946 +186 +0.79% $74.98 23,650 31 May 2024 Direct F2
transaction IRTC Common Stock Other $7,861 +110 +0.47% $71.46 23,760 29 Nov 2024 Direct F3
transaction IRTC Common Stock Award $0 +15,293 +64% $0.000000 39,053 25 Feb 2025 Direct F4
transaction IRTC Common Stock Award $0 +6,732 +17% $0.000000 45,785 26 Feb 2025 Direct F5
transaction IRTC Common Stock Sale $890,536 -7,942 -17% $112.13 37,843 26 Feb 2025 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2022 through November 30, 2023. This transaction is exempt from Section 16(b) under Rule 16b-3.
F2 Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2023 through May 31, 2024. This transaction is exempt from Section 16(b) under Rule 16b-3.
F3 Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2024 through November 30, 2024. This transaction is exempt from Section 16(b) under Rule 16b-3.
F4 Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on May 24, 2022.
F5 These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F6 These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.